Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. Total Liabilities 2017–2025
Sunshine Biopharma Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Sunshine Biopharma Inc. total liabilities as of December 31, 2025: 7.0M, a 0.27% decrease year-over-year.
- Sunshine Biopharma Inc. total liabilities for 2025 were 7.0M, a 0.27% decrease from 2024.
- Sunshine Biopharma Inc. total liabilities for 2024 were 7.1M, a 14.99% increase from 2023.
- Sunshine Biopharma Inc. total liabilities for 2023 were 6.1M, a 19.39% decrease from 2022.
- Sunshine Biopharma Inc. total liabilities for 2022 were 7.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Sunshine Biopharma Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $7 |
| 2023 | $6 |
| 2022 | $8 |
| 2021 | $2 |
| 2020 | $2 |
| 2019 | $1 |
| 2018 | $1 |
| 2017 | $1 |
Sunshine Biopharma Inc. Total Liabilities — FAQ
Sunshine Biopharma Inc. (SBFM) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SBFM's total liabilities history?
The chart and table above show Sunshine Biopharma Inc.'s total liabilities by year and by quarter, including the growth rate.